- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more
- Locations
-
- Medizinische Universität Innsbruck Innsbruck, Tyrolia, Austria
- Medizinische Universität Graz Graz, Austria
- BKH Kufstein Kufstein, Austria
- Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
Clinical trial condition
Multiple Myeloma (MM)
Explore clinical trials studying Multiple Myeloma (MM). Study availability and eligibility vary by location and protocol.
61 public trials
22 recruiting studies
Multiple Myeloma (MM) trial results
Recruiting
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
NCT06767254
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS Meldola, Forlì-Cesena, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
- ARNAS "G. Brotzu" di Cagliari Cagliari, Italy
- Azienda Ospedaliera Universitaria Federico II Naples, Italy
Not yet recruiting
HP-001 Plus Dexamethasone for Relapsed/Refractory Multiple Myeloma With Extramedullary Disease
NCT07811986
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, 300000 Tianjin, China
Not yet recruiting
Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"
NCT07746232
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- IRCCS Istituto Tumori "G. Paolo II - U.O.C. Ematologia e Terapia Cellulare Bari, Italy
- A.O.U. di Bologna - Policlinico S. Orsola Malpighi Bologna, Italy
- A.O. Spedali Civili di Brescia Brescia, Italy
- Istituto Oncologico Veneto IRCCS - UOC Oncoematologia Castelfranco Veneto, Italy
Not yet recruiting
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
NCT07029776
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
Not yet recruiting
Safety and Efficacy of Elranatamab Plus Isatuximab, Bortezomib, and Lenalidomide in Ultra-High-Risk Multiple Myeloma
NCT07789522
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Not yet recruiting
A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma
NCT07735546
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not yet recruiting
Neurocognitive Trajectories After BCMA CAR-T
NCT07740317
- Conditions
- Blood Protein Disorders, CART Therapy, Cardiovascular Diseases, +15 more
- Locations
-
- Atrium Health Levine Cancer Charlotte, North Carolina, United States
NCT07740486
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified
Not yet recruiting
Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification
NCT07687004
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China